144: Filer Information

Filer CIK

0001672659

Filer CCC

XXXXXXXX

Is this a LIVE or TEST Filing?

LIVE

TEST

Submission Contact Information

Name

Phone

E-Mail Address

144: Issuer Information

Name of Issuer

Mineralys Therapeutics, Inc.

SEC File Number

001-41614

Address of Issuer

150 N. RADNOR CHESTER RD.
SUITE F200
RADNOR
PENNSYLVANIA
19087

Phone

(888) 378-6240

Name of Person for Whose Account the Securities are To Be Sold

Rodman David Malcom

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Officer

144: Securities Information

Title of the Class of Securities To Be Sold

Name and Address of the Broker

Number of Shares or Other Units To Be Sold

Aggregate Market Value

Number of Shares or Other Units Outstanding

Approximate Date of Sale

Name the Securities Exchange

Common stock

Merrill Lynch
225 Liberty St
Floor 37
New York � NY � 10281

14056

401789.92

82498101

05/13/2026

NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class

Date you Acquired

Nature of Acquisition Transaction

Name of Person from Whom Acquired

Is this a Gift?

Date Donor Acquired

Amount of Securities Acquired

Date of Payment

Nature of Payment *

Common stock

05/13/2026

Exercise of employee stock options

Mineralys Therapeutics, Inc.

7707

05/13/2026

Broker assisted cashless exercise

Common stock

12/11/2024

Exercise of employee stock options

Mineralys Therapeutics, Inc.

12/11/2024

Cash

Common stock

05/12/2025

Exercise of employee stock options

Mineralys Therapeutics, Inc.

6346

05/12/2025

Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller

Title of Securities Sold

Date of Sale

Amount of Securities Sold

Gross Proceeds

SEC Form 144 filed by Mineralys Therapeutics Inc.